Navigation Links
Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
Date:6/24/2009

Seventy-Seven Percent of Surveyed Physicians Will Increase Their Use of Carbapenems In the Next Five Years, According to a New Report from AMR and Decision Resources

MALVERN, Pa. and WALTHAM, Mass., June 24 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that availability in both intravenous and oral formulation is a leading drug attribute that surveyed physicians prefer for the treatment of complicated urinary tract infections (UTIs) in the hospital setting. Antibiotics available in interchangeable oral and parenteral formulations can facilitate step-down therapy and discharge from the hospital to the outpatient setting.

"Physicians prescribe a wide variety of antibiotics for UTIs, mainly from the quinolone and cephalosporin classes," stated Lisa Arias, analyst at Decision Resources. "These broad-spectrum agents are popular first-line agents in UTIs, and oral quinolones, in particular, have become a popular choice for first-line, step-down and discharge therapy."

The new report entitled Hospital Anti-Infectives Insight Series: Urinary Tract Infections also finds that extended-spectrum beta-lactamase-producing and quinolone-resistant gram-negative pathogens are among the most concerning pathogens, and that 77 percent of surveyed physicians expect to increase their prescribing of carbapenems for complicated UTIs in the next five years. These potent, broad-spectrum antibiotics are especially useful for treating gram-negative infections involving resistant organisms.

About Hospital Anti-Infectives Insight Series

AMR and Decision Resources' Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with Decision
'/>"/>

SOURCE Decision Resources; Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
2. LMS integrated obstetrics solution achieves general availability
3. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
4. PA Breast Cancer Coalition Announces Special Press Availability for PA Breast Cancer Coalition Annual Conference
5. Pelosi to Hold Press Availability with SCHIP Family Tomorrow Morning
6. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
7. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
8. Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
9. Visage Imaging Expands Availability of Its Advanced Visualization Offering
10. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
11. Dblur Announces the Availability of a Software Lens(TM) Enabled Chip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 AquaPrint Solutions in Thomson, IL is ... with a newly-designed Harley Davidson motorcycle gas tank. A couple ... with an idea of taking a split tank motorcycle that ... transforming it into a work of art. , In ... several toilet seats that had been dipped in a water ...
(Date:6/19/2013)... Chicago is cracking down on bed bugs. New ... will require landlords to exterminate any and all reported bed ... ordinance also makes tenants responsible for reporting signs of bed ... often include disposing of furniture, bedding, and more. , In ... did more bed bug business in Chicago than any other ...
(Date:6/19/2013)... Orlando, FL (PRWEB) June 19, 2013 Fit ... and Andrea Laing recently held a charity boot camp in ... cystic fibrosis. The fitness boot camp franchise hosted ... a.m. to 11 a.m. with 75 boot camp participants and ... June charity boot camp marks the second fundraiser held for ...
(Date:6/19/2013)... June 19, 2013 The Cancer Support ... promise of cancer care for the whole patient with ... the Cancer Support Community. This inaugural event, held at ... Emanuel, MD., Ph.D., recognition of Congress members who have ... voices of patients and families currently engaged in the ...
(Date:6/19/2013)... UT (PRWEB) June 19, 2013 Ethigen ... BRCA1 and BRCA2 testing service , providing next-generation sequencing ... available individually, or as part of an expanded hereditary ... additional genes with known links to cancer risk: MLH1, ... SMAD4, BMPR1A, CDH1, MET, FH, FLCN, PDGFRA, and KIT. ...
Breaking Medicine News(10 mins):Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3
... Concerted efforts by the University of Utah researchers in the ... an implanted device// that would transmit the nerve impulses from ... on a belt and then to the bionic arm. This ... a real one. ,Sensors placed in the artificial ...
... and China's first facial transplant patient would have to wait ... surgery has been a success. He is showing signs of ... ,Li Guoxing, bear attack victim underwent a partial ... a hospital in north-western China on the 14th of April. ...
... brain can explain why men and women experience pain ... of certain pain-relief drugs, reveals a new study conducted ... Center for Behavioral Neuroscience (CBN). ,Although the ... highlight that similar differences occur in humans as well. ...
... Bulgarian nurses and a Palestinian doctor accused of infecting hundreds ... next month.// , ,The sources in the Bulgarian foreign ministry ... ,The retrial follows the December verdict of Libya's ... say they were tortured into confessing. , ,The allegation ...
... emergence of bird flu in Ethiopia has been dismissed by ... that were tested for the presence of the H5N1 virus. ... a panel discussion organized on Thursday that no outbreak of ... daily surveillance conducted in several parts of the country. ...
... Bharatiya Janata Party General Secretary, Pramod Mahajan is currently critical ... April) morning at his residence.// Pramod is currently being ... is said to be critical. , ,Mr.Mahajan, a known ... chest. The bullets were fired at close range and went ...
Cached Medicine News:Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2Health News:Review of Pramod Mahajan's Injuries 2
(Date:6/19/2013)... ZIONA, Israel , June 19, 2013 ... results from a phase I study in volunteers, and ... Parkinson,s patients, of ND0612, were presented at the 2013 ... is a proprietary levodopa/carbidopa liquid drug formula under development ... that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... 19, 2013   Life Technologies Corporation ... agreement granting Suzhou Ribo Life Sciences (Ribo) the ... in China using Life,s ... siRNA molecules in combination with Invivofectamine® Rx to ... diseases with high unmet medical need in the ...
(Date:6/19/2013)... Juni 2013 Specialty Coating ... Entwicklung von SCS microRESIST™, einer antimikrobiellen ... Beschichtung mit Parylene gelungen ist. SCS ... Parylene mit antimikrobiellen Eigenschaften und erlaubt ... auf beschichteten medizinischen Geräten. ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... THE WOODLANDS, Texas , Jan. 25 In response ... York Times article, " Radiation Offers New Cures and Ways to ... patients and the general public understand that the benefits received from radiation therapy ... disease with help from the US Oncology physician network, and their loved ones, ...
... , , , MOUNTAIN VIEW, Calif. ... enrollment of its pivotal US study for the ArterX Vascular ... patients who were scheduled to receive a synthetic vascular graft ... applications involved the placement of arteriovenous dialysis access grafts, carotid ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2